Data gathered: December 26
AI Stock Analysis - Teva Pharmaceutical (TEVA)
Analysis generated May 4, 2024. Powered by Chat GPT.
Teva Pharmaceutical Industries Limited is a global pharmaceutical company that specializes in generic and specialty medicines, with a focus on neurological, respiratory, oncology, and autoimmune diseases among other therapeutic areas. Headquartered in Israel, Teva is one of the largest generic drug manufacturers in the world and has a complex portfolio of products and a strong pipeline of generic and specialty medications. The company is operating in a highly competitive and regulated market but has built a reputation for producing affordable and high-quality drugs.
Stock Alerts - Teva Pharmaceutical (TEVA)
 |
Teva Pharmaceutical | December 18 Price is up by 5.1% in the last 24h. |
|
Teva Pharmaceutical | December 17 Price is up by 21.1% in the last 24h. |
|
Teva Pharmaceutical | December 10 Web Traffic is down by 42.2% over the last month. |
|
Teva Pharmaceutical | December 10 Employee Rating is down by 2.7% over the last month. |
Alternative Data for Teva Pharmaceutical
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 581 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 121,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | 18 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 75 | Sign up | Sign up | Sign up |
| Facebook Followers | 54,769 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 7 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 26,469 | Sign up | Sign up | Sign up |
| Twitter Followers | 10,638 | Sign up | Sign up | Sign up |
| Twitter Mentions | 19 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 8,190 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | 74 | Sign up | Sign up | Sign up |
| Business Outlook | 61 | Sign up | Sign up | Sign up |
| Linkedin Employees | 28,366 | Sign up | Sign up | Sign up |
About Teva Pharmaceutical
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
| Price | $22.42 |
| Target Price | Sign up |
| Volume | 3,020,000 |
| Market Cap | $25.4B |
| Year Range | $12.86 - $22.48 |
| Dividend Yield | 0% |
| PE Ratio | 30.17 |
| Analyst Rating | 83% buy |
| Earnings Date | January 29 '25 |
| Industry | Drug Manufacturers |
In the news
 |
Stock Traders Purchase High Volume of Put Options on Teva Pharmaceutical Industries (NYSE:TEVA)December 23 - ETF Daily News |
 |
Why Teva Pharmaceuticals Industries (TEVA) Skyrocketed?December 23 - Yahoo |
|
Wilmington Savings Fund Society FSB Makes New $50,000 Investment in Teva Pharmaceutical Industries Limited (NYSE:TEVA)December 22 - ETF Daily News |
|
MML Investors Services LLC Reduces Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)December 22 - ETF Daily News |
|
Analysts Set Teva Pharmaceutical Industries Limited (NYSE:TEVA) Target Price at $20.88December 21 - ETF Daily News |
|
Orion Portfolio Solutions LLC Takes Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)December 21 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 4.33B | 4.1B | 2.15B | -437M | 208M | 0.690 |
| Q2 '24 | 4.16B | 3.89B | 2.02B | -846M | 254M | 0.610 |
| Q1 '24 | 3.82B | 3.9B | 1.77B | -139M | 54M | 0.480 |
| Q4 '23 | 3.48B | 3.84B | 2.42B | 429M | 988M | 1.000 |
| Q3 '23 | 3.85B | 3.2B | 1.85B | 69M | 638M | 0.600 |
Insider Transactions View All
| Fox Christine filed to sell 44,104 shares at $16.9. November 21 '24 |
| Grant Angus filed to sell 8,848 shares at $17.3. August 13 '24 |
| Hughes Eric A filed to sell 45,060 shares at $17.3. August 5 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$145.85 0% | 48 |
 |
Eli Lilly and CompanyLLY |
$792.8 0% | 61 |
 |
PfizerPFE |
$26.69 0% | 36 |
 |
AstrazenecaAZN |
$66.3 0% | 54 |
 |
AbbVieABBV |
$180 0% | 59 |
Read more about Teva Pharmaceutical (TEVA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Teva Pharmaceutical?
The Market Cap of Teva Pharmaceutical is $25.4B.
What is Teva Pharmaceutical's PE Ratio?
As of today, Teva Pharmaceutical's PE (Price to Earnings) ratio is 30.17.
When does Teva Pharmaceutical report earnings?
Teva Pharmaceutical will report its next earnings on January 29 '25.
What is the current stock price of Teva Pharmaceutical?
Currently, the price of one share of Teva Pharmaceutical stock is $22.42.
How can I analyze the TEVA stock price chart for investment decisions?
The TEVA stock price chart above provides a comprehensive visual representation of Teva Pharmaceutical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Teva Pharmaceutical shares. Our platform offers an up-to-date TEVA stock price chart, along with technical data analysis and alternative data insights.
Does TEVA offer dividends to its shareholders?
As of our latest update, Teva Pharmaceutical (TEVA) does not offer dividends to its shareholders. Investors interested in Teva Pharmaceutical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Teva Pharmaceutical?
Some of the similar stocks of Teva Pharmaceutical are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.